Nicotinic Acetylcholine Receptors

Nicotinic acetylcholine receptors (nAChRs) are a group of ionotropic receptors found in the central and peripheral nervous systems. They are integral to the normal function of the neuromuscular junction, and are also involved in many neurological processes, including learning, attention, and addiction. nAChRs are named for their affinity for nicotine - a potent agonist of these receptor complexes. These receptors are composed of five subunits, arranged around a central pore through which ions flow when activated. There are multiple subtypes of nAChR, each with different sensitivity to agonists and antagonists, and each with their own distribution across the nervous system. Research into the function of nAChRs has revealed their potential as therapeutic targets for a number of neurological and psychiatric disorders. One example is Alzheimer's disease, where researchers are investigating the use of nAChR agonists to improve cognitive function in patients. Addiction is another area of interest, with studies suggesting that nAChR antagonists may help to reduce nicotine dependence. Therapy targeting nAChRs is an area of active investigation, with the potential to improve outcomes for a range of neurological conditions. As our understanding of these receptors expands, it is likely that we will discover further applications for nAChR-based therapies.